NanoViricides
NNVC
#10565
Rank
NZ$60.28 M
Marketcap
NZ$2.36
Share price
0.76%
Change (1 day)
-20.94%
Change (1 year)

NanoViricides (NNVC) - Net assets

Net assets on the balance sheet as of June 2026 : NZ$15.4 Million

According to NanoViricides's latest financial reports the company has NZ$15.4 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

NanoViricides - Net assets on balance sheet (from 2006 to 2024)

Net assets by year

Year Net assets Change
2023-06-30$NZ$24.23 M-34.48%
2022-06-30$NZ$36.98 M-13.48%
2021-06-30$NZ$42.75 M26.75%
2020-06-30$NZ$33.72 M113.91%
2019-06-30$NZ$15.76 M-39.55%
2018-06-30$NZ$26.08 M-6.03%
2017-06-30$NZ$27.75 M-14.06%
2016-06-30$NZ$32.29 M-31.04%
2015-06-30$NZ$46.83 M75.61%
2014-06-30$NZ$26.66 M157.63%
2013-06-30$NZ$10.35 M-40.02%
2012-06-30$NZ$17.25 M40.56%
2011-06-30$NZ$12.27 M30.29%
2010-06-30$NZ$9.42 M143.08%
2009-06-30$NZ$3.87 M564.68%
2008-06-30$NZ$0.58 M-10.38%
2007-06-30$NZ$0.65 M-68.17%
2006-06-30$NZ$2.04 M-2219.02%
2005-06-30$-NZ$0.1 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Gilead Sciences
GILD
NZ$20.84 B 135,154.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$74.50 B 483,425.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$41.53 B 269,441.59%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$43.22 B 280,405.68%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
-NZ$0.34 Billion-2,296.35%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-NZ$0.81 Billion-5,332.00%๐Ÿ‡บ๐Ÿ‡ธ USA